Skip to content

Celcuity

US · CELC #2398 by market cap Listed 2017
65.78 -5.47 -7.68%
Live - 5344 symbols - heartbeat 345s ago · 2026-10-08 07:00
Pre-market 65.74 -0.06%
After-hours 67.00 +1.85%
Overnight 66.00 +0.33%
Market cap
3.22B
P/B
-252.03
EPS
-3.79
Reader sentiment Are you bullish or bearish on CELC?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions increased by 1 in the most recent period (2026/Q3).
  • Total institutional ownership fell 8.8 percentage points.

Institutional ownership

Held by institutions
112.16% -8.83pp
Institutions
337 +1
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund46.93%
Hedge Fund40.13%
VC/PE Fund11.17%
Public Company10.82%
Individual/Insider9.19%
Private Company1.58%
Sovereign Wealth Fund0.89%
Government Pension Fund0.38%
Insurance Company0.20%

Top holders as of 2026-07-14

Baker Bros. Advisors LP 9.84% · 4.82M sh
Avoro Capital Advisors LLC 6.95% · 3.40M sh
RTW Investments, LP 6.75% · 3.30M sh
Perceptive Advisors LLC 6.53% · 3.20M sh
Brian Sullivan 6.38% · 3.12M sh
BlackRock 6.17% · 3.02M sh
Vanguard Capital Management, LLC 4.40% · 2.15M sh
State Street Global Advisors 4.00% · 1.96M sh
New Enterprise Associates, Inc. 3.50% · 1.71M sh
Soleus Capital Management, L.P. 3.48% · 1.70M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 25 buys · 22 sells

NameRoleStake
Brian Sullivan Chairperson & CEO 6.38%
Lance Laing Co-Founder, Chief Science Officer, VP, Secretary & Director 2.56%
Richard Nigon Independent Director 0.16%
Vicky Hahne Chief Financial Officer 0.04%
Leo Furcht Independent Director 0.02%
Richard Buller Independent Director 0.02%
Polly Murphy Independent Director 0.01%
Charles Romp Director 0.00%
Brightstone Venture Capital -- --
David Dalvey Independent Director --

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-08-13 Brian Sullivan Chairperson & CEO Other Acquisition +80,000 --
2026-08-13 Brian Sullivan Chairperson & CEO Other Derivative Acquisition +120,000 --
2026-08-13 Vicky Hahne Chief Financial Officer Other Acquisition +16,000 --
2026-08-13 Vicky Hahne Chief Financial Officer Other Derivative Acquisition +10,000 --
2026-08-13 Lance Laing Co-Founder, Chief Science Officer, VP, Secretary & Director Other Acquisition +20,000 --
2026-08-13 Lance Laing Co-Founder, Chief Science Officer, VP, Secretary & Director Other Derivative Acquisition +10,000 --
2026-07-13 Baker Bros. Advisors LP -- Open Market Disposition -3,100,000 $102.50
2026-06-09 Richard Buller Independent Director Other Derivative Acquisition +12,503 $10.69
2026-06-09 Richard Buller Independent Director Other Derivative Disposition -12,503 $10.69
2026-06-09 Polly Murphy Independent Director Other Derivative Acquisition +14,048 $10.69
2026-06-09 Polly Murphy Independent Director Other Derivative Disposition -14,048 $10.69
2026-06-04 Richard Nigon Independent Director Other Acquisition +1,530 --
2026-06-04 David Dalvey Independent Director Other Acquisition +1,530 --
2026-06-04 Leo Furcht Independent Director Other Acquisition +1,530 --
2026-06-04 Richard Buller Independent Director Other Acquisition +1,530 --
2026-06-04 Charles Romp Director Other Acquisition +1,530 --
2026-06-04 Polly Murphy Independent Director Other Acquisition +1,530 --
2026-06-01 Lance Laing Co-Founder, Chief Science Officer, VP, Secretary & Director Derivative Exercise and Retained +1,000 $9.89
2026-05-18 Richard Buller Independent Director Other Acquisition +1,029 --
2026-05-18 Richard Buller Independent Director Other Disposition -1,029 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 07:00:00 · For reference only, not investment advice and not tailored to your situation.